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ORIGINAL ARTICLE
Atherosclerosis plays an important role in stroke.
It has been reported that about 68% of patients
with ischemic stroke had carotid atherosclerosis.1
Years of observational research have shown that
well-known host factors such as family history,
genetic susceptibility, and lifestyle influence the
development of atherosclerosis, but these risk fac-
tors do not represent the totality of risk for the
development of the disease. Over the years, herpes
viruses have attracted increasing attention with
regard to their potential role in the process of ath-
erosclerosis. In particular, the putative relation-
ship between human cytomegalovirus (HCMV)
and atherosclerosis has been a favorite subject of
investigation in both human and animal studies.
HCMV is an important human pathogen with
the ability to cause disease in immunocompro-
mised subjects. HCMV is a complex virus, whose
genes are divided into three groups based on their
time of appearance in infected cells.2 Gene expres-
sion in HCMV-infected cells occurs in an ordered
sequential fashion. After infection of the host, the
viral ORFs (open reading frames) are expressed
in a highly organized and regulated cascade of
immediate-early (IE), early (E) and late (L) tran-
scription. IE genes are the first genes to be tran-
scribed after viral infection and require no de novo
protein synthesis for their expression. IE gene
products are required for subsequent expression
and regulation of early genes and may be required
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for L gene expression. Early gene expression occurs
after IE protein synthesis but before viral DNA
replication. The early gene does not require viral
DNA synthesis for expression. L gene expression
occurs after the initiation of viral DNA synthesis.
Viral RNA at late times originates from all regions
of the genome. It has been postulated that all
HCMV L genes are transcribed early but that late
mRNA is not maximally translated until later as
a result of posttranscriptional controls.3
A prominent characteristic of this virus is that
it persists in the host after a primary infection.4 Sev-
eral reports suggested that the arterial wall might
be a site for the latent virus and it was suggested
that frequent reactivation from this latent state
might contribute significantly to the pathogenesis
of atherosclerosis.5
Although a number of clinical and experimen-
tal studies suggested that reactivation of latent
HCMV in arterial tissues might contribute to ath-
erogenesis, these studies only involved Cauca-
sians, and mostly focused on cardiovascular and
peripheral arteries. Some reports suggested that
the locations of cerebral atherosclerosis varied in
different ethnic populations. More atherosclerotic
plaques formed in external carotid than internal
carotid arteries in Caucasians, while there were
more plaques in the internal carotid arteries in
Asian and African populations.6,7 Accordingly, we
chose to study the internal carotid arteries of pa-
tients of the ethnic Han population, the biggest
race in China.
Here, we investigated the association between
the presence of HCMV and carotid atherosclerosis
and examined the relevance of the infectious agent




The study group included 35 patients who died
of ischemic stroke, including 25 males and 10 fe-
males, aged from 50 to 76 years. The 20 subjects
of the control group included 13 males and
seven females, matched for age and sex with the
study group. The control group did not have cere-
bral vascular disease, HCMV-associated disease or
an immunocompromised status. The presence of
antibodies to IgG for HCMV in the blood samples
of the 55 subjects was examined (Virion-Serion,
Germany), and the seropositive patients were re-
moved from the control group. All cases were eth-
nic Han Chinese, and their internal carotid arteries
were available by autopsy within 24 hours of death,
and with the consent of their families.
Histology
Tissue type was scored according to the guidelines
of the American Heart Association,8 with type
I–III being classified as early lesions, and type
IV–VI as advanced lesions. For every patient the
mean lesion area and number were calculated then
compared between groups. These arteries were iso-
lated and fixed in 3.7% phosphate buffered sa-
line (PBS)-formaldehyde solution for histologic
examination and determination of HCMV.
Type I lesions were defined as lesions contain-
ing isolated macrophage foam cells in the media.
Type II lesions (fatty streaks) were defined as le-
sions consisting primarily of layers of macrophage
foam cells. Type III lesions were the lesion type
between type II and type IV, and were also called
preatheroma. Type IV lesions, which were called
atheroma, had aggregated extracellular lipid pools
and a large confluent lipid core. In type V lesions,
the lipid core had expanded and the fibrotic corn
had become thicker and covered the entire le-
sion. Lesions with fissures and/or ulcerations and/
or thrombotic deposits were defined as type VI
lesions, or complicated lesions.
Polymerase chain reaction (PCR)
To detect the HCMV DNA in intracranial arteries,
two pairs of primers were used. One pair of oligo-
nucleotide primers specific for the HCMV (strain
AD169) major IE exon 4 region produced a 248-
bp amplimer. The other specific for the HCMV L
gene region was described by Gozlan et al.9 The L
gene encoding the major capsid protein produced
a 263-bp amplimer (Table 1).
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Sections (5 μm) were cut with a sterile blade
and transferred into a sterile reaction tube. The
DNA was extracted by phenol, chloroform and
isoamyl alcohol, which has been described pre-
viously.10 The reaction conditions were as follows:
94°C for 5 minutes, 35 cycles at 94°C for 40 sec-
onds, 59°C for 60 seconds (IE gene) and 60°C for
60 seconds (L gene), and 72°C for 60 seconds,
and 72°C for 10 minutes.
Each PCR assay was run with at least two neg-
ative (H2O instead of the template or primers) and
two positive controls (HCMV strain AD169 DNA
instead of the template) to prevent false-negative
and false-positive results. PCR products were 
analyzed by agarose gel electrophoresis and pho-
tographed under ultraviolet light. The pBR322/
Hinf I was used as DNA size markers (1631, 517,
506, 396, 344, 298, 221, 220, 154, and 75 bp).
Immunohistochemistry (IHC)
For immunohistochemical analysis, mouse mon-
oclonal antibody anti-HCMV (strain AD169) IE
antigen (Chemicon) and L antigen (Novacastra)
were used.
The sections were incubated overnight at 4°C
with a 1:200 dilution of a monoclonal antibody
anti-IE antigen of HCMV, and a 1:50 dilution of
a monoclonal antibody anti-L antigen separately.
Then, biotinylated affinity purified horse anti-
mouse IgG (Santa Cruz) and biotin-streptavidin-
HRP complex were used to develop the reaction.11
The positive cells were counted under five high-
power fields in five continuous sections.
As a positive control, human intestinal mu-
cous membranes were used, which were previ-
ously shown to have the inclusion body of HCMV
by hematoxylin and eosin (H&E) staining. PBS
instead of the monoclonal antibody of HCMV 
IE and L antigens was used for the negative 
controls.
In situ hybridization (ISH)
The DNA probes of HCMV IE and L genes were
obtained with the same primers used for PCR.
These probes were directly labeled by adding PCR
DIG Labeling Mix (Roche) instead of the dNTP to
the PCR reaction mix. The predicted DNA probe
size was 248 bp and 263 bp respectively. The ISH
protocol performed on 5-μm thick tissue sec-
tions has been described previously.12 Specifically,
the hybridized DNA probe was visualized by 
diaminobenzidine-4HCl-substrate, and counter-
stained with hematoxylin. Five high-power fields
in five continuous sections were selected to count
the number of positive cells.
Human intestinal mucous membranes were
used as the positive control and the hybridiza-
tion solution lacking the HCMV DNA probe was
used as a negative control.
Statistical analysis
SPSS version 10.0 (SPSS Inc., Chicago, IL, USA)
was used for data management and analysis. The
χ2 test was used for non-parametric data. Fisher’s
exact test was used if the χ2 test was not suitable.
Differences were taken as significant with a p value
of less than 0.05.
Results
Histology of arteries
Atherosclerosis in the arteries of all 35 patients
from the study group was confirmed by H&E stain-
ing. In the 35 internal carotid arteries of the pa-
tient group, 18 were type I–III, and the rest were
Table 1. Primers used in polymerase chain reaction and in situ hybridization
Genes Forward primer (5–3) Reverse primer (5–3)
HCMV IE GCGCCTTTAATA/TGATGGGA TTCATCCTTTTTAGCACGGG 
HCMV L GTGATCCGACTGGGCGAAAA GAGCGCGTCCACAAAGTCTA
HCMV = human cytomegalovirus; IE = immediate-early; L = late.
HCMV in carotid arteries
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type IV–VI. The arteries of the control group were
normal.
Detection of HCMV genes in arteries by PCR
The positive specific band of the HCMV IE gene
was present in 21 of 35 (60%) patients (Figure 1),
which was significantly more than in the control
group (p = 0.032; Table 2). The specific band was
positive in seven of 18 (38.9%) type I–III, which
was significantly less than in type IV–VI (82.4%)
(p = 0.009; Table 3). 
For the L gene, there was no significant differ-
ence between patients and controls (p = 1.000;
Table 2), or between type I–III and type IV–VI
(p = 0.228; Table 3).
Detection of HCMV antigens in arteries 
by IHC
Table 2 demonstrates significantly more instances
of HCMV IE antigen in patients (34.3%) than in
controls (10.0%) (p = 0.047). In the 12 patients
with a positive stain for HCMV IE antigen, two
were atherosclerotic type I–III (11.1%), and the
other 10 were type IV–VI (58.8%) (Table 3), and
this difference was significant (p = 0.003; Table 3).
Positive IE antigens were found in the intima and
smooth muscle cells (Figure 2). There were sig-
nificantly more positive cells in atherosclerotic
type I–III than in type IV–VI (p = 0.015; Table 4).
For the L antigen, four of 35 (11.4%) patients
showed positivity in the intracranial arteries,
which was not significantly different from controls
(5.0%) (p = 0.643; Table 2). In these four positive
cases, three were type IV–VI and one was type I–III,
with no significant difference (p = 0.117; Table 3).
Detection of HCMV genes in arteries by ISH
There was a significant difference in positivity for
the HCMV IE gene between the patient group
Figure 1. Polymerase chain reaction-amplified HCMV IE
gene fragment of 248 bp. Agarose gel electrophoresis. Lane
1 = DNA marker pBR322/Hinf I. Lane 2 = positive control.
Lane 3 = negative control. Lanes 4–10 = patient group.
Table 2. Detection of human cytomegalovirus (HCMV) genes/proteins in intracranial arteries by polymerase
chain reaction (PCR), immunohistochemistry (IHC), and in situ hybridization (ISH)
HCMV IE genes/protein HCMV L genes/protein
Patients, n (%) Controls, n (%) p Patients, n (%) Controls, n (%) p
PCR 21/35 (60.0) 6/20 (30.0) 0.032 7/35 (20.0) 4/20 (20.0) 1.000
IHC 12/35 (34.3) 2/20 (10.0) 0.047 4/35 (11.4) 1/20 (5.0) 0.643
ISH 14/35 (40.0) 2/20 (10.0) 0.018 4/35 (11.4) 2/20 (10.0) 1.000
IE = immediate-early; L = late.
Table 3. Detection of human cytomegalovirus (HCMV) genes/protein in intracranial arteries of patients with
different types of atherosclerosis by polymerase chain reaction (PCR), immunohistochemistry (IHC),
and in situ hybridization (ISH)
HCMV IE genes/protein HCMV L genes/protein
Type I–III, n (%) Type IV–VI, n (%) p Type I–III, n (%) Type IV–VI, n (%) p
PCR 7/18 (38.9) 14/17 (82.4) 0.009 2/18 (11.1) 5/17 (29.4) 0.228
IHC 2/18 (11.1) 10/17 (58.8) 0.003 1/18 (5.56) 3/17 (17.6) 0.117
ISH 4/18 (22.2) 10/17 (58.8) 0.027 1/18 (5.56) 3/17 (17.6) 0.117
IE = immediate-early; L = late.
L. Yi, et al
778 J Formos Med Assoc | 2008 • Vol 107 • No 10
and the control group (Table 2). There were sig-
nificantly more positive findings for the HCMV
IE gene in atherosclerosis type IV–VI than in type
I–III (p = 0.027; Table 3).
Histologically, the HCMV nucleic acid se-
quences detected with the in situ DNA hybridiza-
tion technique were mostly located in the
apparently normal portion and in the atheroscle-
rotic plaque of the target arteries in the patient
group. On a few occasions, the viral nucleic acid
was located in the thickened intimal layer.
Sequential sections stained with hematoxylin
showed that the DNA hybridization reactivity was
mostly located in smooth muscle cells in the ar-
terial media (Figure 3). There was more positiv-
ity in cells of type I–III than type IV–VI, but there
was no significant difference (p = 0.072; Table 4).
For the L gene, there was no significant differ-
ence between the two groups (p = 1.000; Table 2),
or between type I–III and type IV–VI (p = 0.117;
Table 3).
Discussion
Various epidemiologic studies have demonstrated
an association between prior HCMV infection and
atherosclerosis. In the fourth decade of life, when
atherosclerosis manifests in humans, 50–80% of
the general population in the industrialized world
has already encountered the virus, as shown by
the high percentage of seropositives.13 After the
initial infection, most likely at a young age, HCMV
switches to a state of latency with intermittent
periods of reactivation in which small amounts
of infectious virus are shed.14 These periods of
reactivation are common and may be induced by
stress or other stimuli.15
We observed that the proportion of cases that
tested positive for HCMV IE but not L antigen
and DNA was statistically greater in stroke pa-
tients compared with the control population. In
addition, the positivity for the HCMV IE gene and
antigen paralleled the severity of atherosclerosis
(Table 3). This implies that IE not only is associ-
ated with atherosclerosis formation, but also its
progression. Among the three methods for detec-
tion of the IE gene, PCR was the most sensitive.
Although IHC and ISH were not as sensitive as
Figure 2. Detection of HCMV IE antigen in the intracranial
artery wall of an atherosclerosis patient by immunohisto-
chemistry (Brown stain; original magnification, 200×).
Table 4. Average number of human cytomegalovirus
IE-positive cells in the intracranial 
arteries of patients with different types 
of atherosclerosis determined by
immunohistochemistry (IHC) and 
in situ hybridization (ISH) per field
Type I–III Type IV–VI p
IHC 7.50 ± 0.61 4.58 ± 0.59 0.015
ISH 5.93 ± 0.78 5.28 ± 1.04 0.072
IE = immediate-early.
Figure 3. Detection of HCMV IE gene region in the in-
tracranial artery wall of an atherosclerosis patient by in situ
hybridization (Brown stain; original magnification, 400×).
PCR, they could localize the virus, the number of
positive cells could be counted, and it was help-
ful to demonstrate the location and pathologic
features of the virus infection. The ISH was more
sensitive and specific than IHC by its specific
combination with a probe to detect the virus
gene (Table 3).
The positive IE protein was found in cells with
lipid deposits, while the IE gene was found not
only in plaque but also in largely normal cells.
There was a wider distribution of the IE gene
than its protein. This may be the reason why ISH
showed a higher positive detection (22.2%) in
type I–III than IHC (11.1%), while it was the
same in type IV–VI (58.6%). This demonstrated
that the ISH was more sensitive than IHC in the
early lesion, because it could detect the cells not
presenting with infection.
HCMV nucleic acid was located mainly in nor-
mal cells, and with atherosclerosis development,
the cellular construction is destroyed and replaced
by deposits of calcium and lipid. This might be the
main reason why fewer positive cells were found
in type IV–VI than in type I–III (Table 4).16
Atherosclerosis is a chronic inflammatory dis-
order of the large and medium sized arteries.17
The primary event in the atherosclerotic process
is the injury or dysfunction of endothelial cells.
Subsequently, the permeability of the vascular
wall of the affected endothelium increases, lead-
ing to adhesion of platelets and monocytes/
macrophages to the endothelium. Concomitantly,
smooth muscle cells migrate, proliferate and se-
crete extracellular matrix proteins, causing inti-
mal thickening, ultimately contributing to the
aggravation of the atherosclerotic process.
During the development of atherosclerosis, a
key step is the recruitment and accumulation of
leukocytes, specifically monocytes and T lympho-
cytes, in the intimal space. The migration of these
leukocytes is regulated by chemoattractant cy-
tokines or chemokines, leading to an increase in
the monocytes and T lymphocytes present in the
vessel walls.18 After epithelial cells are infected, the
increase in cytokines may enhance the adherence
of white cells to the epithelium, the monocytes
would transfer latent HCMV to the arterial wall,
then the immunologic and inflammatory reaction
activated by the virus could worsen the injury of
the intima and formation of neointima.19,20 Even
a tiny amount of virus could start this process.21
HCMV was reported to induce smooth mus-
cle cell migration and proliferation, increase mod-
ified low-density lipoprotein uptake in vascular
smooth muscle cells,22 promote leukocyte influx,
and induce an increased expression of adhesion
molecules (e.g. intercellular adhesion molecule-
1), inflammatory cytokines (e.g. interleukin-6)
and chemokines (e.g. monocyte chemoattractant
protein-1).18,23,24 Additionally, one of the IE gene
products of HCMV, IE2-84, binds to and inhibits
p53 transcriptional activity, and protects smooth
muscle cells from p53-mediated apoptosis. The
inhibitory effect of IE2-84 on p53 could increase
the number of smooth muscle cells. The pathway
by which HCMV infection predisposes to smooth
muscle cell accumulation thereby contributes to
restenosis and atherosclerosis.25
Here, both IHC and ISH detected the virus IE
gene and protein in the intima and media layer,
not only in cells with lipid deposits, but also in
plaque and largely normal cells. The presence of
HCMV IE gene-positive cells in normal cells raises
the possibility that infection of HCMV occurred
before atherosclerotic lesions began to appear. Se-
veral reports suggested that the arterial wall might
be a site of latency for this virus and it was sug-
gested that frequent reactivation from this latent
state might contribute significantly to the patho-
genesis of atherosclerosis.5 The endothelial cells
and smooth muscle cells were supposed to be
the latent infection location of HCMV.26
In the control group, all three methods pre-
sented positive findings for IE and L genes and
proteins, and PCR demonstrated 30% positive
findings for the IE gene. It was reported that there
was a high HCMV infection rate in the popula-
tion. In the United States, according to serum lev-
els of HCMV IgG, the positivity rate was 10–15%
in young people, rising to 40–50% in those over
35 years, and to 60–70% in those older than 65
years. This trend paralleled the incidence of 
HCMV in carotid arteries
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atherosclerosis.5 Therefore we cannot exclude
the possibility of infection of HCMV before 
atherosclerosis formation.
None of the three methods showed significant
differences in the detection of the L gene between
patient and control groups. Late HCMV genome
expression is strictly regulated by IE and E gene
products. L gene expression occurs after the initi-
ation of viral DNA synthesis. Viral RNA at late
times originates from all regions of the genome.
The L antigen is an indicator of complete viral rep-
lication.27 In the immunocompetent host, HCMV
only leads to latent infection which will last the
life of the host, without causing virus toxemia and
symptoms, i.e. no formation or release of infec-
tious virus particles. This finding of negativity for
the L gene and antigen in the vascular walls leads
to the question of whether plaque formation was
triggered by a direct HCMV effect on the athero-
sclerotic lesion. Several in vitro studies implied
that cytomegalovirus infection activated a sys-
temic inflammatory response, thereby exacerbat-
ing atherosclerotic plaque formation in the long
term,28 and suggested that HCMV might also have
an indirect effect on the atherosclerotic process.
A local effect of the virus on the atherosclerotic
process seemed to be less important, and indirect
effects might be the dominant factor in aggravating
atherosclerosis.29
Here, we found HCMV in the internal carotid
artery walls in Chinese ischemic stroke patients.
The HCMV IE gene was associated with the patho-
logic process of arthrosclerosis and the vessel
walls might be the dormant virus infection site.
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